- Conditions
- Coronary Artery Disease
- Interventions
- Microport Firehawk stent, 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
- Device
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,720 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 44
- States / cities
- Birmingham, Alabama • Gilbert, Arizona • La Jolla, California + 38 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Coronary Artery Disease
- Interventions
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Device
- Lead sponsor
- Medtronic Vascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 416 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 23
- States / cities
- Huntsville, Alabama • La Jolla, California • Riverside, California + 19 more
- Conditions
- Coronary Artery Disease
- Interventions
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Device
- Lead sponsor
- Medtronic Vascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 205 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 21
- States / cities
- Huntsville, Alabama • La Jolla, California • Riverside, California + 17 more
- Conditions
- Congenital Heart Disease in Children
- Interventions
- Ductal Arterial Stent, Systemic-to-Pulmonary Artery Shunt
- Device · Procedure
- Lead sponsor
- Carelon Research
- Other
- Eligibility
- 1 Day to 30 Days
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 20 more
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System Treatment Followed by one-month DAPT
- Combination Product
- Lead sponsor
- Medtronic Vascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 752 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 4
- States / cities
- East Syracuse, New York • New York, New York • Anderson, South Carolina + 1 more
- Conditions
- Coronary Artery Disease
- Interventions
- Resolute Onyx Stent - 2.25 mm - 4.0 mm
- Device
- Lead sponsor
- Medtronic Vascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 12
- States / cities
- La Jolla, California • Clearwater, Florida • Springfield, Illinois + 9 more
- Conditions
- Coronary Artery Disease
- Interventions
- Resolute Onyx Stent - 2.0 mm
- Device
- Lead sponsor
- Medtronic Vascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 17
- States / cities
- La Jolla, California • Clearwater, Florida • Springfield, Illinois + 13 more
- Conditions
- Coronary Disease, Coronary Stenosis
- Interventions
- FFR guided PCI, CABG, Resolute Integrity Stent, Resolute Onyx Stent
- Procedure · Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 1,500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2024
- U.S. locations
- 13
- States / cities
- Palo Alto, California • Stanford, California • Decatur, Georgia + 9 more
- Conditions
- Atherosclerosis
- Interventions
- Eagle Eye Platinum digital IVUS catheter with optional SyncVision, Resolute Onyx Drug Eluting Stent, Onyx Frontier Drug Eluting Stent, Onyx TruStar Drug Eluting Stent, Onyx TruCor Drug Eluting Stent
- Device
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3,100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 40
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • La Jolla, California + 36 more